Back

Efficacy and Safety of Evolocumab Compared With Continued Lipoprotein Apheresis: Results of a Randomised, Controlled, Open-Label Study

27 August 2017 (08:30 - 18:00)
Organised by:
Congress Presentation Part of: Late-Breaking Science Posters Lipids (Epidemiology and Prevention) ESC Premium Access ESC Congress 2017

About the speaker

Photo
Doctor Patrick Moriarty

University of Kansas Medical Center, Kansas City (United States of America)

6 More presentations in this session

Presentation thumbnail
Effect of QRS duration Normalized for Left Ventricular Size on Cardiac Resynchronization Therapy in Heart Failure Patients with a Narrow (<130 ms) QRS complex: A Subgroup Analysis of the EchoCRT Trial
Doctor N. Varma (Cleveland, US)
Presentation thumbnail
REDEFINE trial: a double-blind, randomized trial with losartan to study RV dysfunction after repair of tetralogy of Fallot
Doctor J. Bokma (Amsterdam, NL)
Slides
Presentation thumbnail
A Randomized Controlled Trial Evaluating the Efficacy of Long-term Use of Beta-blocker in Patients with ST-segment Elevation Myocardial Infarction treated with Primary Percutaneous Coronary Interventi
Mr H. Watanabe (Wakayama, JP)
Slides
Presentation thumbnail
Intensive Longterm Prevention Program vs. Usual Care After Acute Myocardial Infarctions - The IPP study
Professor H. Wienbergen (Bremen, DE)
Presentation thumbnail
Innovative mobile Health (mHealth) technology integrating clinical decision support and patient involvement to improve clinical management of patients with atrial fibrillation
Professor Y. Guo (Beijing, CN)
Slides

Access the full session

Session thumbnail
Late-Breaking Science Posters

The Event

Event poster

ESC Congress 2017

27 August 2017 08:30 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources